Recent studies demonstrate Curcumae kwangsiensis radix’s superior anti-thrombotic properties, with Guangxi-origin samples showing exceptional activity through advanced quality marker identificat...
Recent advancements in AI and chemometrics are transforming quality assessment of Curcumae kwangsiensis radix, offering new possibilities for standardized thrombosis treatments in traditional Chinese ...
New research shows significant regional differences in bioactive compounds of Curcumae kwangsiensis radix, with Guangxi varieties showing superior cardiovascular benefits. Cutting-edge studies reveal ...
Recent studies highlight regional variations in CKR’s bioactive compounds and their therapeutic effects, sparking debates on standardization methods in TCM. New research reveals significant regi...
New research reveals Guangxi-sourced CKR has 15% higher curcumin content than Yunnan’s, with distinct pharmacological effects on thrombosis through spectrum-effect relationship analysis. Groundb...
A comparative study on Curcumae Kwangsiensis radix (CKR) from Guangxi and Yunnan reveals key bioactive compounds for blood circulation enhancement and stasis elimination. Recent research highlights th...
